PROCTER & GAMBLE HEALTH
|
The Current P/E Ratio of PROCTER & GAMBLE HEALTH is 34.40.
Share Price | ₹4,697.5 | Apr 19,2024 |
Market Cap | ₹7,797.9 Cr | |
Earnings-TTM | ₹226.7 Cr | TTM-Standalone Results |
Price/Earnings | 34.40x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of PROCTER & GAMBLE HEALTH
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹7,797.9 Cr] as on Apr 19,2024
(/) Earnings [ ₹226.7 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 34.40x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay 34.40 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PROCTER & GAMBLE HEALTH !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PE (Price/Earnings) ratio chart of PROCTER & GAMBLE HEALTH
PE Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/e ratio for fiscal years ending Jun2023 to Dec2018 averaged 40.70x.
- PROCTER & GAMBLE HEALTH 's operated at median p/e ratio of 37.97x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/e ratio peaked in Jun2021 at 52.52x.
- PROCTER & GAMBLE HEALTH 's p/e ratio hit its five-year low in Jun2020 of 26.57x.
How does PROCTER & GAMBLE HEALTH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
PROCTER & GAMBLE HEALTH | 226.65 | 34.40 | 7,797.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.60 | 365,311.0 |
CIPLA LTD | 3,744.03 | 29.01 | 108,623.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 19.03 | 99,134.3 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 31.41 | 92,794.9 |
DIVIS LABORATORIES LTD | 1,382.97 | 70.43 | 97,408.4 |
MANKIND PHARMA LTD | 1,743.30 | 53.67 | 93,565.4 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 57.47 | 85,858.5 |
LUPIN LTD | 1,809.74 | 38.96 | 70,506.8 |
AUROBINDO PHARMA LTD | 2,777.89 | 22.93 | 63,697.4 |
ABBOTT INDIA LTD | 1,145.58 | 48.47 | 55,528.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PROCTER & GAMBLE HEALTH 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.03x |
Max industry PE | 70.43x |
Median industry PE | 38.96x |
Average industry PE | 40.58x |
You may also like the below Video Courses